ScienceDex / Researcher record
Southan, Garry John
- Radikal Therapeutics, Inc. (no department on record)
From the FY2012 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
NIH Funding · FY2012
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2011 | $1,159,544 | 3 | #5,845 |
| 2012 | $1,721,096 | 6 | #3,447 |
| 2013 | $648,083 | 1 | #11,142 |
| 2014 | $1,419,403 | 2 | #4,447 |
| 2015 | $810,596 | 1 | #8,787 |
| 2017 | $1,531,102 | 2 | #3,921 |
| 2018 | $1,541,211 | 2 | #4,158 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20113 records
- FY2012 · selected6 records
- FY20131 record
- FY20142 records
- FY20151 record
- FY20172 records
- FY20182 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2018Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2012 award records by amount
NIH award records listing Southan, Garry John as a PI. Multi-PI records show the full award amount for context.
- 5U01ES021154-02U01Contact PIMultifunctional therapeutics for treatment of acute chlorine inhalational injury$681.6Kaward amount
- 1R43DK093168-01A1R43Contact PIA Thioredoxin Mimetic for Radiocontrast Nephropathy$260.5Kaward amount
- 1R43GM100503-01R43Contact PIPeroxynitrite Decomposition Catalyst and Nitric Oxide Donor for Endotoxemia$252.3Kaward amount
- 1R43HL108382-01A1R43Contact PIA Hybrid PARP Inhibitor and Redox Catalyst for Lung Transplantation$249.5Kaward amount
- 1R43HL112341-01R43Contact PIBifunctional Nitric Oxide Donor Refractory to Nitrate Tolerance$240.5Kaward amount
- 3U01ES021154-02S1U01Contact PIMultifunctional therapeutics for treatment of acute chlorine inhalational injury$36.8Kaward amount
Award organization
Organizations that administered FY2012 awards listing Southan, Garry John as a PI.
FY2012 award administered by Radikal Therapeutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardRadikal Therapeutics, Inc.
- 2011$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #5845
- 2012$2M Cumulative Funding
- 2012Entered Top 25% NationallyRanked #3447
- 2014Program/Center Grant Leader
- 2015$5M Cumulative Funding